Mirae Asset Global Etfs Holdings Ltd. Biotechnology

Mirae Asset Global Etfs Holdings Ltd.

$39.6 Billion
Q2 2024

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
CMPX Compass Therapeutics, Inc.	$182M	$45,000 0.0% of portfolio	45,556	Q2 2024 New
IGMS Igm Biosciences, Inc.	$377M	$44,000 0.0% of portfolio	6,508	Q2 2024 New
RAPT Rapt Therapeutics, Inc.	$85.7M	$44,000 0.0% of portfolio	14,643	Q2 2024 New
BMEA Biomea Fusion, Inc.	$240M	$43,000 0.0% of portfolio	9,762	Q2 2024 New
PDSB Pds Biotechnology Corp	$93.6M	$42,000 0.0% of portfolio	14,643	Q2 2024 New
FGEN Fibrogen Inc	$30M	$41,000 0.0% of portfolio	47,183	Q2 2024 New
CTXR Citius Pharmaceuticals, Inc.	$59.9M	$39,000 0.0% of portfolio	68,334	Q2 2024 New
PLX Protalix Bio Therapeutics, Inc.	$57.7M	$39,000 0.0% of portfolio	34,167	Q2 2024 New
KOD Kodiak Sciences Inc.	$256M	$38,000 0.0% of portfolio	16,270	Q2 2024 New
MCRB Seres Therapeutics, Inc.	$89.3M	$36,000 0.0% of portfolio	50,437	Q2 2024 New
XFOR X4 Pharmaceuticals, Inc	$42.6M	$36,000 0.0% of portfolio	63,453	Q2 2024 New
ALLK Allakos Inc.	$114M	$34,000 0.0% of portfolio	34,167	Q2 2024 New
PMVP Pmv Pharmaceuticals, Inc.	$79.4M	$34,000 0.0% of portfolio	21,151	Q2 2024 New
ACET Adicet Bio, Inc.	$52.4M	$33,000 0.0% of portfolio	27,659	Q2 2024 New
CCCC C4 Therapeutics, Inc.	$296M	$32,000 0.0% of portfolio	6,993	Q2 2024 New
VIGL Vigil Neuroscience, Inc.	$101M	$32,000 0.0% of portfolio	8,135	Q2 2024 New
BCAB Bio Atla, Inc.	$76.2M	$31,000 0.0% of portfolio	22,778	Q2 2024 New
PRLD Prelude Therapeutics Inc	$43.3M	$30,000 0.0% of portfolio	8,135	Q2 2024 New
IPSC Century Therapeutics, Inc.	$84.8M	$29,000 0.0% of portfolio	11,389	Q2 2024 New
GRTS Gritstone Bio, Inc.	$1.46M	$28,000 0.0% of portfolio	45,556	Q2 2024 New
IKNA Ikena Oncology, Inc.	$63.8M	$26,000 0.0% of portfolio	16,270	Q2 2024 New
OMGA Omega Therapeutics, Inc.	$52.2M	$26,000 0.0% of portfolio	13,016	Q2 2024 New
SGMO Sangamo Therapeutics, Inc	$449M	$26,000 0.0% of portfolio	74,842	Q2 2024 New
OVID Ovid Therapeutics Inc.	$91.5M	$23,000 0.0% of portfolio	30,913	Q2 2024 New
CUE Cue Biopharma, Inc.	$60.9M	$22,000 0.0% of portfolio	17,897	Q2 2024 New
KZR Kezar Life Sciences, Inc.	$504M	$21,000 0.0% of portfolio	35,794	Q2 2024 New
RLYB Rallybio Corp	$32.1M	$21,000 0.0% of portfolio	16,270	Q2 2024 New
NVCT Nuvectis Pharma, Inc.	$158M	$20,000 0.0% of portfolio	3,254	Q2 2024 New
VOR Vor Biopharma Inc.	$36.5M	$19,000 0.0% of portfolio	19,524	Q2 2024 New
ALVR Allovir, Inc.	$57.7M	$18,000 0.0% of portfolio	26,032	Q2 2024 New
BTAI Bio Xcel Therapeutics, Inc.	$19.1M	$14,000 0.0% of portfolio	11,389	Q2 2024 New
IMRX Immuneering Corp	$50.1M	$14,000 0.0% of portfolio	11,389	Q2 2024 New
AADI Aadi Bioscience, Inc.	$44.8M	$11,000 0.0% of portfolio	8,135	Q2 2024 New
EYEN Eyenovia, Inc.	$16.8M	$9,000 0.0% of portfolio	16,270	Q2 2024 New
RPHM Reneo Pharmaceuticals, Inc.	$41.1M	$9,000 0.0% of portfolio	6,508	Q2 2024 New
AVTE Aerovate Therapeutics, Inc.	$66.5M	$8,000 0.0% of portfolio	4,881	Q2 2024 New
CARA Cara Therapeutics, Inc.	$18.3M	$6,000 0.0% of portfolio	24,405	Q2 2024 New
BIVI Biovie Inc.	$83M	$2,000 0.0% of portfolio	6,508	Q2 2024 New
SBTX Silverback Therapeutics, Inc.	$0	$0 0.0% of portfolio	16,228	Q2 2024 New

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirae Asset Global Etfs Holdings Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mirae Asset Global Etfs Holdings Ltd. with notifications on news.